Over the past 12 months, 3 insiders at BioAge Labs, Inc. filed 10 open-market SEC Form 4 transactions on BIOA: 0 purchases worth $0 and 10 sales worth $6.1M. Insiders have been net sellers over this period. The most recent filing was on Mar 2, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 26 | Paul D RubinChief Medical Officer | SELL | 7.4K | $20.30 | $151K |
| Feb 2, 26 | Paul D RubinChief Medical Officer | SELL | 7.4K | $18.75 | $139K |
| Jan 13, 26 | Kristen FortneyChief Executive Officer | SELL | 233.1K | $18.12 | $4.2M |
| Jan 13, 26 | Goldstein Dov A MdChief Financial Officer | SELL | 11.7K | $21.08 | $240K |
| Jan 2, 26 | Paul D RubinChief Medical Officer | SELL | 7.4K | $12.85 | $96K |
| Dec 9, 25 | Paul D RubinChief Medical Officer | SELL | 18.0K | $12.00 | $216K |
| Dec 4, 25 | Paul D RubinChief Medical Officer | SELL | 68.9K | $10.19 | $702K |
| Oct 3, 24 | Vijay Satyanand PandeDirector | BUY | 25.3K | $19.90 | $504K |
| Oct 2, 24 | Vijay Satyanand PandeDirector | BUY | 67.1K | $19.73 | $1.3M |
| Oct 1, 24 | Vijay Satyanand PandeDirector | BUY | 126.8K | $19.73 | $2.5M |
| Sep 27, 24 | Shane BartonPrincipal Accounting Officer | BUY | 2.6K | $18.00 | $47K |
| Sep 27, 24 | Bihua ChenOther | BUY | 450.0K | $18.00 | $8.1M |
| Sep 27, 24 | Vijay Satyanand PandeDirector | BUY | 900.0K | $18.00 | $16.2M |
| Sep 27, 24 | Patrick G EnrightDirector | BUY | 400.0K | $18.00 | $7.2M |
| Sep 27, 24 | James HealyDirector | BUY | 588.9K | $18.00 | $10.6M |
| Sep 27, 24 | Rekha HemrajaniDirector | BUY | 3.0K | $18.00 | $54K |
Over the past 12 months, insiders at BioAge Labs, Inc. filed 0 open-market purchases worth $0 and 10 sales worth $6.1M on BIOA, which makes them net sellers over the period. The most recent Form 4 was filed on Mar 2, 26.
The largest recent open-market BIOA insider purchase in our data was $16.2M by Vijay Satyanand Pande, Director, filed on Sep 27, 24.
3 different insiders at BioAge Labs, Inc. filed open-market SEC Form 4 transactions on BIOA over the last 12 months.
InsiderTape plots every BIOA insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every BioAge Labs, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →